Skip to content
Search

Latest Stories

RPS launches new policy on AI in pharmacy practice

The opportunities, challenges and potential applications of AI within pharmacy
gettyimages

AI technologies have the potential to transform the way that pharmacists and pharmacy teams work

The Royal Pharmaceutical Society (RPS) has published a new policy outlining how artificial intelligence (AI) can be used to support pharmacy practice and improve patient care.

The content has been developed in consultation with RPS members, Expert Advisory Group members, Board members, multi-professional experts in digital technology and AI, and external stakeholders including the General Pharmaceutical Council (GPhC).


The policy highlights the opportunities, challenges and potential applications of AI within pharmacy now and in the future.

RPS President, Professor Claire Anderson, acknowledges that AI technologies have the potential to transform pharmacy practice, noting that “there are some great examples where it’s already in use.”

“We must optimise the opportunities that these advancing technologies can bring to enhance patient access to care, improve patient experience, support clinical decision making and improve the safety and efficiency of the medicines supply chain.

“Our policy provides a framework to ensure AI is harnessed safely and effectively to support pharmacists and patients,” she adds.

Key areas of the policy include:

  • Improving patient care: AI is a tool to support pharmacy professionals to improve the safe and effective use of medicines in any setting, and achieve better patient outcomes
  • Education and training: Investment in AI skills and knowledge is vital to equip the pharmacy workforce for the future
  • Data protection: Pharmacists must safeguard patient data and ensure compliance with privacy standards when using AI tools
  • Collaboration: AI tools must be developed in partnership with pharmacists, data scientists, developers and patients and to ensure they meet clinical needs
  • Governance and safety: AI systems must adhere to strict regulatory standards, with ongoing testing and oversight to safeguard patients
  • Patient focus: Transparency and diverse data are essential to ensure fair and effective AI-driven care.

Will AI lead to job displacement?

The RPS says that AI will enhance job roles, rather than replace them.

The organisation explains: “The automation of routine tasks could allow all staff to take on a more patient-centred focus and ultimately improve patient care.

“While AI will radically alter how work gets done and who does it, the larger impact will be in complementing and augmenting human capabilities, not replacing them.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less